126458-16-0 Usage
General Description
"(R)-2-Methyl piperazine (L)tartaric acid salt" is a chemical compound composed of the (R)-2-methyl piperazine molecule and the L-tartaric acid molecule in a salt form. These organic molecules are often used in the pharmaceutical and chemical industries. (R)-2-Methyl piperazine, a derivative of piperazine, is usually used as an intermediate in drug synthesis, especially in antipsychotics and antidepressants. L-Tartaric acid, on the other hand, is a naturally occurring organic acid commonly found in many plants like grapes, and is primarily known for its culinary uses such as an acidulant in foods and beverages. As a salt, they can combine to repurpose functions in various applications in research and industry. However, the specific properties, usage, and safety measures of the compound can vary depending on the individual requirements and contexts.
Check Digit Verification of cas no
The CAS Registry Mumber 126458-16-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,4,5 and 8 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 126458-16:
(8*1)+(7*2)+(6*6)+(5*4)+(4*5)+(3*8)+(2*1)+(1*6)=130
130 % 10 = 0
So 126458-16-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H12N2.C4H6O6/c1-5-4-6-2-3-7-5;5-1(3(7)8)2(6)4(9)10/h5-7H,2-4H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t5-;1-,2?/m11/s1
126458-16-0Relevant articles and documents
NOVEL PROCESS
-
Page 24-25, (2010/02/05)
The present invention relates to a process for the preparation of compounds which are therapeutically active in the central nervous system. In one aspect, the invention relates to a process for the preparation of compounds of the general formula (I). The invention also relates to (2R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine, hydrochloride and a process for preparing the same. Another object of the present invention is a compound of the formula (I). Another object of the present invention is a method for the treatment or prophylaxis of a serotonin-related disorder, comprising administering to a subject in need thereof an effective amount of the compound above; as well as the use of said compound to manufacture a medicament for the treatment of a serotonin-related disorder.
